Tirzepatide being a dual GLP-1 and GIP agonist, it is suggested that the GIP part of twin agonism could possibly be to blame for the extra gain, supplied the potential good thing about GIP receptor agonism on peripheral insulin sensitization. Consequently, tirzepatide was more effective than dulaglutide in lowering fasting dietary TAG [six,seven].